Milestone Pharmaceuticals Capital Expenditures (CapEx) Growth & History (MIST)

Milestone Pharmaceuticals's capital expenditures (capex) was $302,000 for fiscal 2025.

View full Milestone Pharmaceuticals company overview

Milestone Pharmaceuticals annual capital expenditures (capex) history

Milestone Pharmaceuticals annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$302,000$269,000+815.15%
20242024-12-31$33,000−$79,000−70.54%
20232023-12-31$112,000−$160,000−58.82%
20222022-12-31$272,000
20192019-12-31$413,000$408,000+8160.00%
20182018-12-31$5,000

Milestone Pharmaceuticals capital expenditures (capex) trends

Between the periods ended 2018-12-31 and 2025-12-31, Milestone Pharmaceuticals's capital expenditures (capex) increased from $5,000 to $302,000, a change of $297,000. The latest reported quarter, Q2 2026, shows $26,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Milestone Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about MIST yet. Start the conversation.

Write the first post